Cite Filings / APVO / 0000950170-24-025428

Feed Companies Filings Check

Sign in

10-K

Annual Report

Aptevo Therapeutics Inc. Filed 2024-03-05 Acc 0000950170-24-025428

Documents 1

10-K Annual Report , apvo-20231231.htm

Around this filing

2025-02-14 10-K Annual Report
2024-03-05 8-K Bylaws or fiscal year change
2024-03-05 4 EVP, COO acquired 9,167 shares (option exercise)
2024-03-05 4 SVP, GC, BD & Corp Affairs acquired 7,334 shares (option exercise)
2024-03-05 4 President and CEO acquired 22,501 shares (option exercise)
2024-03-05 10-K Annual Report
2023-03-30 10-K Annual Report

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)
SEC Structured Data (opens in new tab)

Loading apvo-20231231.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…